

Publisher: Bentham Science Publishers
E-ISSN: 1875-628x|1|3|194-197
ISSN: 1570-1808
Source: Letters in Drug Design & Discovery, Vol.1, Iss.3, 2004-07, pp. : 194-197
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
We present the SAR study that led us to identification of the first inhibitors of type 7 17&bgr;- hydroxysteroid dehydrogenase (17&bgr;-HSD). The conversion of E1 into E2 is reduced by nearly 90 % by 17&bgr;-(Nalkylformamido)- 4-methyl-4-aza-5&agr;-androstan-3-one compounds bearing a side chain containing 7 to 10 carbon atoms when tested at 0.3 &mgr;M.
Related content






Inhibitors of 17&bgr;-Hydroxysteroid Dehydrogenase Type 1
Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. :


17β-Hydroxysteroid dehydrogenase inhibitors: a patent review
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. :